Related Experiment Video

Updated: May 30, 2026

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers

Forrest M Kievit1, Miqin Zhang

  • 1Department of Materials Science and Engineering, University of Washington, Seattle, WA 98195, USA.

Advanced Materials (Deerfield Beach, Fla.)
|August 16, 2011
PubMed

Insights

Cancer nanotheranostics utilizes nanotechnology for combined cancer imaging and therapy. Nanoparticles offer improved targeted delivery and treatment for challenging cancers like metastatic and drug-resistant types.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Cancer nanotheranostics integrates imaging and therapy using nanotechnology.
  • Nanomaterials offer enhanced specificity and effectiveness against difficult-to-treat cancers.
  • Metastatic, drug-resistant, and cancer stem cells present significant therapeutic challenges.

Purpose of the Study:

  • To review nanotheranostic particles for cancer imaging and therapy.
  • To discuss biological barriers affecting nanotheranostic delivery.
  • To explore nanotherapeutics for overcoming current cancer treatment limitations.

Main Methods:

  • Review of nanotheranostic particle types and their imaging applications.
  • Analysis of biological barriers (e.g., blood-brain barrier) for nanomedicine.
  • Examination of nanotherapeutics for targeted cancer cell delivery and treatment.

Main Results:

  • Nanotheranostics can improve targeted delivery and treatment efficacy.
  • Understanding biological barriers is crucial for successful nanomedicine.
  • Nanoparticle engineering holds promise for overcoming therapeutic challenges.

Conclusions:

  • Nanotheranostics represent a promising approach for advanced cancer treatment.
  • Targeted delivery via nanotechnology can enhance therapeutic outcomes.
  • Further development of nanoparticles is essential for future cancer therapies.

More Related Videos

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy08:09

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

Published on: April 6, 2015

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting07:54

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.